Core Laboratories (NYSE:CLB) Trading 5.6% Higher – Here’s What Happened

Core Laboratories Inc. (NYSE:CLB) rose 5.6% on Monday . The company traded as high as $11.69 and last traded at $11.72. 166,235 shares traded hands during trading, a decline of 71% from the average session volume of 566,757 shares. The stock had previously closed at $11.10.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CLB shares. Wall Street Zen downgraded Core Laboratories from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. Weiss Ratings cut Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, June 24th. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus price target of $12.00.

Core Laboratories Stock Up 5.1%

The business has a 50-day simple moving average of $12.75 and a 200-day simple moving average of $15.84. The company has a market cap of $537.76 million, a PE ratio of 17.95, a P/E/G ratio of 2.14 and a beta of 1.00. The company has a quick ratio of 1.50, a current ratio of 2.05 and a debt-to-equity ratio of 0.42.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 EPS for the quarter, hitting the consensus estimate of $0.06. The company had revenue of $121.80 million during the quarter, compared to analyst estimates of $122.99 million. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The firm’s revenue was down 1.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.14 EPS. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Equities research analysts anticipate that Core Laboratories Inc. will post 0.56 EPS for the current year.

Core Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Monday, May 11th were paid a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend was Monday, May 11th. Core Laboratories’s dividend payout ratio is currently 6.15%.

Hedge Funds Weigh In On Core Laboratories

Several hedge funds and other institutional investors have recently modified their holdings of CLB. CWA Asset Management Group LLC purchased a new position in Core Laboratories during the fourth quarter worth approximately $9,978,000. Goldman Sachs Group Inc. boosted its stake in Core Laboratories by 185.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 845,251 shares of the oil and gas company’s stock worth $13,549,000 after buying an additional 548,657 shares during the last quarter. Disciplined Growth Investors Inc. MN grew its holdings in Core Laboratories by 9.7% in the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company’s stock valued at $73,787,000 after buying an additional 528,976 shares in the last quarter. MAC Alpha Capital Management LP purchased a new stake in Core Laboratories in the 4th quarter valued at $5,016,000. Finally, Heartland Advisors Inc. acquired a new stake in shares of Core Laboratories in the 1st quarter worth $2,518,000. 97.81% of the stock is owned by hedge funds and other institutional investors.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.